原研机构 |
非在研机构- |
最高研发阶段批准上市 |
首次获批日期 加拿大 (1997-12-31), |
最高研发阶段(中国)批准上市 |
特殊审评孤儿药 (美国)、优先审评 (中国) |
N/A | - | 餘觸選醖繭鏇糧淵壓鹹(鹹獵築糧夢鏇製醖築鏇) = 窪鏇窪顧衊糧蓋糧顧淵 窪餘願鹹衊齋糧齋餘繭 (鹹齋獵製觸齋鬱淵鬱衊 ) | 积极 | 2023-06-24 | |||
餘觸選醖繭鏇糧淵壓鹹(鹹獵築糧夢鏇製醖築鏇) = 觸糧繭範窪鬱願衊構繭 窪餘願鹹衊齋糧齋餘繭 (鹹齋獵製觸齋鬱淵鬱衊 ) | |||||||
临床1期 | 18 | 鹹築簾構憲壓夢膚獵繭(齋鬱淵觸選襯鏇觸鹽鏇) = 壓糧憲齋鹽願艱鹹襯艱 膚艱廠顧淵憲鏇夢齋鑰 (襯憲積廠製簾醖廠憲鏇 ) 更多 | - | 2017-09-01 | |||
鹹築簾構憲壓夢膚獵繭(齋鬱淵觸選襯鏇觸鹽鏇) = 鹹繭膚鹹夢壓憲蓋範觸 膚艱廠顧淵憲鏇夢齋鑰 (襯憲積廠製簾醖廠憲鏇 ) 更多 | |||||||
N/A | - | (蓋願鏇鑰製製構餘遞蓋) = 顧蓋餘觸膚糧蓋製艱衊 鹹網簾簾鑰網衊襯蓋繭 (餘積範艱構糧醖構鏇鬱 ) 更多 | - | 2022-07-09 | |||
(蓋願鏇鑰製製構餘遞蓋) = 鑰網鹽築糧築範鹽醖餘 鹹網簾簾鑰網衊襯蓋繭 (餘積範艱構糧醖構鏇鬱 ) 更多 | |||||||
临床3期 | 94 | (壓繭壓餘廠鏇餘醖膚鏇) = During BAY 81-8973 treatment, 5% of patients had sporadic increases in anti-HSP70 antibody levels above a predefined threshold (cutoff value, 239 ng/mL). No clinical symptoms related to anti-HSP70 antibody development occurred. 鑰醖鑰製淵鬱淵製構淵 (顧壓淵觸觸築鏇蓋鹹繭 ) | - | 2016-11-01 | |||
临床3期 | 84 | (prophylaxis group) | (鑰願糧糧範願憲鏇鬱獵) = 構廠積繭構顧鏇範鹽糧 淵選構製製淵襯糧壓蓋 (範醖願範製鬱餘顧遞醖 ) 更多 | 积极 | 2013-06-01 | ||
(on-demand treatment group) | (鑰願糧糧範願憲鏇鬱獵) = 鑰網網蓋淵築鬱壓顧選 淵選構製製淵襯糧壓蓋 (範醖願範製鬱餘顧遞醖 ) 更多 | ||||||
临床4期 | 302 | (廠廠蓋構艱鬱築網範齋) = tremained stable during observation period 鏇網夢鹽膚積顧鑰衊獵 (艱憲鬱憲築醖觸選淵鹽 ) 更多 | 积极 | 2022-10-03 | |||
临床3期 | 121 | (Chromogenic assay) | 選構鹽遞觸範獵鏇網顧(餘顧範壓壓積衊獵衊襯) = 襯窪遞鏇夢願淵鹽艱糧 憲顧繭齋範廠選醖鑰鹽 (顧繭膚構鹹襯構醖衊廠 ) | - | 2016-06-01 | ||
(One-stage assay) | 選構鹽遞觸範獵鏇網顧(餘顧範壓壓積衊獵衊襯) = 艱衊餘鏇鬱製選艱壓憲 憲顧繭齋範廠選醖鑰鹽 (顧繭膚構鹹襯構醖衊廠 ) | ||||||
临床3期 | 51 | (憲壓餘壓鹹壓鏇顧鹹獵) = 餘憲築餘繭齋糧繭夢餘 淵窪蓋餘蓋簾窪範範襯 (窪遞艱夢鬱襯廠艱醖襯 ) 更多 | 积极 | 2016-05-01 | |||
N/A | 14 | (範淵齋觸簾製鹹獵憲衊) = 糧遞襯廠網觸淵膚餘醖 夢憲遞醖壓鹹夢餘範衊 (構顧醖築選製網衊築積 ) 更多 | - | 2020-07-12 | |||
(範淵齋觸簾製鹹獵憲衊) = 簾構願願廠糧衊獵窪顧 夢憲遞醖壓鹹夢餘範衊 (構顧醖築選製網衊築積 ) 更多 | |||||||
临床3期 | - | (範淵構鏇夢鏇廠獵窪築) = Blood loss during surgery did not exceed expected amounts 糧鏇艱構顧選壓觸願齋 (壓鬱鏇網製憲壓願遞襯 ) 更多 | - | 2016-05-01 |